Common side effectsnausea, vomiting, constipation, and appetite suppressionare generally dose-dependent and may resolve with titration or discontinuation
The disadvantages are periods of hospitalisation (one to three weeks depending on the centre), high upfront cost and lack of reversibility
For research peptides, a robust quality control program relies on a suite of sophisticated techniques performed by independent, third-party laboratories to eliminate any potential for bias
However, patients with complex arrhythmias or advanced heart failure should be monitored more closely
Compound Reference Data Compound: IGF-1 LR3 CAS Number: 946870-92-4 (also reported as 143045-27-6 for the related sequence) Molecular Formula: C400H625N111O115S9 Molecular Weight: ~9,111 Da (83 amino acids) Sequence: Synonyms: Long-R3-IGF-1, Long Arg3-IGF-I, LR3-IGF-1, LONGR3 IGF-I Selected Published Studies The following peer-reviewed studies were conducted using animal models or in vitro cell-culture systems
Metformin: Historical Overview